PDND
Phytochemical Database for Neurological Disorders
search icon
Advanced search

Phytochemical Name : Epigallocatechin Gallate
PCNDIDE0036
Pubchem CID : 65064
Molecular formula: C22H18O11

Molecular weight : 458.400

Canonical SMILES : C1C(C(OC2=CC(=CC(=C21)O)O)C3=CC(=C(C(=C3)O)O)O)OC(=O)C4=CC(=C(C(=C4)O)O)O

Synonymes : (-)-Epigallocatechin gallate|EGCG|989-51-5|Epigallocatechin gallate|Epigallocatechin 3-gallate|Tea catechin|Epigallocatechin-3-gallate|Teavigo|Epigallocatechin-3-monogallate|(-)-Epigallocatechin-3-o-gallate|(-)-epigallocatechin 3-gallate|EGCG cpd|PF-EGCg 90|(-)-Epigallocatechol gallate|NVP-XAA 723|CCRIS 3729|(2R,3R)-5,7-Dihydroxy-2-(3,4,5-trihydroxyphenyl)chroman-3-yl 3,4,5-trihydroxybenzoate|epigallo-catechin gallate|Catechin deriv.|UNII-BQM438CTEL|BQM438CTEL|CHEBI:4806|Epigallocatechingallate|Epigallocatechin-gallate|Epigallocatechol, 3-gallate, (-)-|C22H18O11|L-Epigallocatechin gallate|(2R,3R)-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2H-chromen-3-yl 3,4,5-trihydroxybenzoate|EPIGALOCATECHIN GALLATE|CHEMBL297453|[(2R,3R)-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2H-chromen-3-yl] 3,4,5-trihydroxybenzoate|DTXSID1029889|(-)-epigallocatechin 3-O-gallate|[(2R,3R)-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)chroman-3-yl] 3,4,5-trihydroxybenzoate|Benzoic acid, 3,4,5-trihydroxy-, (2R,3R)-3,4-dihydro-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-2H-1-benzopyran-3-yl ester|epigallocatechin-3-O-gallate|(2R,3R)-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2H-1-benzopyran-3-yl 3,4,5-trihydroxybenzoate|Gallic acid, 3-ester with epigallocatechol, (-)-|DTXCID80567|(-)-Epigallocatechin gallate (85% (-)-epigallocatechin gallate, 10% (-)-epigallocatechin, 5% (-)- epicatechin gallate)|Benzoic acid, 3,4,5-trihydroxy-, 3,4-dihydro-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-2H-1-benzopyran-3-yl ester, (2R-cis)-|CAS-989-51-5|SMR000449288|SR-01000759328|(-)-EPIGALLOCATECHIN-3-O-GALLATE (USP-RS)|(-)-EPIGALLOCATECHIN-3-O-GALLATE [USP-RS]|Epigallocate|Sunphenon|(-)-EGCG|Epigallocic acid|Teatannin II|GTPs,Anagen|2kdh|3oob|4awm|(-)-cis-2-(3,4,5-Trihydroxyphenyl)-3,4-dihydro-1(2H)-benzopyran-3,5,7-triol 3-gallate|C22-H18-O11|EGCG, Anagen|KDH|Epigallocatcchin Gallate|Epigallocatechol Gallate|Spectrum_000316|SpecPlus_000277|Spectrum2_000168|Spectrum3_000244|Spectrum4_001541|Spectrum5_000102|Galloyl-L-epigallocatechol|EGCG [WHO-DD]|D0E9DB|D0U2BH|EGCG [MI]|3-O-Galloylepigallocatechin|(-)-Epigallocatechin gallat|(-)-Epigallocatehin gallate|SCHEMBL35258|BSPBio_001628|epigallocatechin-gallate-(-)|KBioGR_002002|KBioSS_000796|SPECTRUM210239|cid_65064|MLS000758300|MLS001424000|DivK1c_006373|SPBio_000035|Epigallocatechin monogallate, B|GTPL7002|MEGxp0_001166|Epigallocatechin gallate, Anagen|(-)-Epigallocatechin-3-gallate|ACon1_001054|KBio1_001317|KBio2_000796|KBio2_003364|KBio2_005932|KBio3_001128|(-)-cis-3,3',4',5,5',7-Hexahydroxy-flavane-3-gallate|HMS2051K21|HMS3649E08|3-O-Galloyl-(-)-epigallocatechin|EPIGALLOCATECHIN 3-O-GALLATE|Tox21_201468|Tox21_303457|BDBM50070942|CCG-38378|FR-109|LMPK12030005|s2250|AKOS015918182|CS-1258|CS-O-01489|DB12116|DS-9030|EPIGALLOCATECHIN GALLATE [INCI]|LS-2197|NC00078|SDCCGMLS-0066550.P001|(-)-Epigallocatechin gallate, >=95%|(-)-Epigallocatechin-3-gallate; EGCG|NCGC00164319-01|NCGC00164319-02|NCGC00164319-03|NCGC00164319-04|NCGC00164319-06|NCGC00257243-01|NCGC00259019-01|AC-34075|BP-30205|HY-13653|E0694|SW197458-3|C09731|M01719|(-)-Epigallocatechin gallate, >=97.0% (HPLC)|(-)-Epigallocatechin gallate, analytical standard|A845931|Q393339|SR-01000946601|Q-100914|SR-01000759328-5|SR-01000759328-6|SR-01000946601-1|ANTIOXIDANT MODEL (TRAMP) -EPIGALLOCATECHIN GALLATE|Epigallocatechin-3-gallate 1000 microg/mL in Acetonitrile|(-)-Epigallocatechin gallate, >=80% (HPLC), from green tea|Epigallocatechin gallate, primary pharmaceutical reference standard|((2R,3R)-2-(3,4,5-trihydroxyphenyl)-5,7-dihydroxy-chroman-3-yl) 3,4,5-trihydroxybenzoate|(-)-Epigallocatechin-3-O-gallate, United States Pharmacopeia (USP) Reference Standard|(2R,3R)-5,7-Dihydroxy-2-(3,4,5-trihydroxyphenyl)chroman-3-yl3,4,5-trihydroxybenzoate|[5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)chroman-3-yl] 2,3,4-trihydroxybenzoate|Epigallocatechin gallate, Pharmaceutical Secondary Standard; Certified Reference Material|(-)-cis-3,4-Dihydro-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-1(2H)-benzopyran-3-yl Gallate|(-)-EPIGALLOCATECHIN GALLATE (85% (-)-EPIGALLOCATECHIN GALLATE, 10% (-)-EPIGALLOCATECHIN, 5% (-)-EPICATECHIN GALLATE)|(-)-EPIGALLOCATECHIN-3-O-GALLATE (EGCG) (CONSTITUENT OF POWDERED DECAFFEINATED GREEN TEA EXTRACT)|(2R,3R)-5,7-Dihydroxy-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2H-chromen-3-yl-3,4,5-trihydroxybenzoate|(2R-cis)-3,4-Dihydro-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-2H-1-benzopyran-3-yl 3,4,5-Trihydroxybenzoate|[(2R,3R)-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2H-chromen-3-yl]3,4,5-trihydroxybenzoate|3,4,5-Trihydroxybenzoic acid (2R,3R)-3,4-dihydro-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-2H-1-benzopyran-3-yl ester|3,4-Dihydro-5,7-dihydroxy-2R-(3,4,5-trihydroxyphenyl)-2H-1-benzopyran-3R-yl-3,4,5-trihydroxybenzoate|Benzoic acid, 3,4,5-trihydroxy-,(2R,3R)-3,4-dihydro-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-2H-1-benzopyran-3-yl ester

Structure
3D structure 2D structure
65064
Predicted properties (NCBI Pubchem)

Physicochemical Properties